Overview
What It Is The Vivistim system is an implanted vagus-nerve stimulator that delivers brief electrical pulses precisely timed with rehabilitation movements. The pairing is intended to enhance neuroplasticity and improve upper-limb motor recovery after chronic ischemic stroke. After implant, patients complete a structured rehabilitation program with stimulation paired to each therapeutic movement.
How It Works Vagus-nerve stimulation timed with movement releases neuromodulators that make the brain more plastic in that moment. Pairing stimulation with high-quality motor practice strengthens the circuits being used—essentially amplifying use-dependent plasticity for arm and hand recovery. This is one of the clearest device-based demonstrations of pairing neuromodulation with rehabilitation.
Conditions - FDA-approved use: upper-limb motor deficits after chronic ischemic stroke (with rehabilitation). - Note: Surgical and stimulation-related risks apply. Evidence from the pivotal VNS-REHAB trial supports clinically meaningful gains in selected patients.
How it is administered
Surgical implantation of a vagus-nerve stimulator, followed by a structured 6-week in-clinic rehabilitation program in which stimulation is paired with therapeutic movements. Home use continues afterward.
Conditions connected in the NPA database
The NPA Treatment Database lists this treatment in connection with 1 condition record. A database relationship does not establish effectiveness, safety, or suitability for an individual.
Related questions
These controlled question pages reference this treatment through stored condition relationships.
Symptoms connected in the NPA database
The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.
Motor Control
- difficulty walking
- muscle stiffness/spasticity
- One-sided weakness or paralysis
- poor balance and coordination
Practical information
Insurance coverage
Increasingly covered by Medicare and many private insurers for eligible chronic ischemic stroke patients.
Cost information
$30,000–$50,000+ for device + implantation + therapy package (before insurance).
Results and outcomes described in the source record
Improvements typically assessed after the 6-week in-clinic phase.
Side effects and risks
Surgical risks (infection, pain, hoarseness, coughing). Most stimulation-related effects are temporary.
Research context in the NPA database
This section reproduces the current database's research summary and detail. Structured citation metadata has not been supplied, so it should not be read as an independently verified literature review.
Research summary
Evidence Level: Strong
What the research shows: A major clinical trial found that pairing vagus nerve stimulation with rehabilitation improved arm function more than rehabilitation alone. Benefits continued in follow-up studies.
Key takeaway: Best suited for people with lasting arm weakness after an ischemic stroke who can still participate in therapy.
Research detail
Overview The Vivistim system is an implanted vagus-nerve stimulator that delivers brief electrical pulses precisely timed with rehabilitation movements. The pairing is intended to enhance neuroplasticity and improve upper-limb motor recovery after chronic ischemic stroke. After surgical placement of the device, patients complete a six-week in-clinic rehabilitation program during which stimulation is triggered with each therapeutic movement; home use continues afterward. The system is FDA-approved on the basis of the pivotal VNS-REHAB trial.
Evidence Base and Published Work • The pivotal VNS-REHAB trial found that pairing vagus-nerve stimulation with rehabilitation improved upper-limb motor function more than rehabilitation alone after chronic ischemic stroke. • Longer-term follow-up data and reviews of paired VNS for post-stroke motor recovery support clinically meaningful gains in appropriately selected patients. • Key published work includes: – Dawson J et al. (2021). “Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial.” Lancet. – Longer-term follow-up data and reviews of paired VNS for post-stroke motor recovery. – Surgical and stimulation-related risks apply. Insurance coverage has expanded. Evidence is strong for the approved indication.
Outcomes Outcomes most frequently described include clinically meaningful gains in arm and hand function after chronic ischemic stroke in appropriately selected patients. Evidence is strong for the approved indication.
Questions to ask a provider
1. Do I meet criteria for the Vivistim paired VNS system for upper-limb recovery after chronic stroke? 2. What does the surgical procedure and the 6-week in-clinic rehabilitation protocol involve? 3. What gains in arm and hand function were seen in the pivotal trial for patients like me? 4. Is the device and associated therapy covered by insurance for my situation? 5. What ongoing home use and follow-up are required after the initial intensive phase?
Website and contact information
Explore the interactive Treatment Database
Continue to compare educational treatment information in the interactive database. The standard disclaimer acknowledgement is required before the database opens.
Explore treatment information in the database